SCALLOP consortium:
genetic regulation of the proteome
The SCALLOP consortium (Systematic and Combined AnaLysis of Olink Proteins) is a collaborative framework for discovery and follow-up of genetic associations with proteins on the Olink Proteomics platform. To date, 35 PIs from 28 research institutions have joined the effort, which now comprises summary level data for more than 70,000 patients and controls from 45 cohort studies. SCALLOP welcomes new members.
Institutions
Cohorts
Samples
Latest Events
- Seminar “The Proteome of Cancer Risk” by Dr. Karl Smith-Byrne
- New preprint – “Genetic mechanisms of 184 neuro-related proteins in human plasma”
- Presentation at Crohn’s and Colitis Foundation webinar
- New Article – “The effect of phenotype and genotype on the plasma proteome in patients with Inflammatory Bowel Disease.”
Introduction from Anders Mälarstig
Our partners
Olink Proteomics utilize their groundbreaking technology to develop panels for precision proteomics. Olink panels offer robust, multiplex biomarker analysis, that help scientists bring new insights into disease processes, enhance biomarker discovery for disease detection and prognosis, and contribute to a deeper understanding of disease biology.